Terms: = Ovarian cancer AND SMARCD1, CRACD1, 6602, ENSG00000066117, Rsc6p, BAF60A, Q96GM5
3 results:
1. miR-223 potentially targets SWI/SNF complex protein smarcd1 in atypical proliferative serous tumor and high-grade ovarian serous carcinoma.
Arts FA; Keogh L; Smyth P; O'Toole S; Ta R; Gleeson N; O'Leary JJ; Flavin R; Sheils O
Hum Pathol; 2017 Dec; 70():98-104. PubMed ID: 29079174
[TBL] [Abstract] [Full Text] [Related]
2. DLEU1 contributes to ovarian carcinoma tumourigenesis and development by interacting with miR-490-3p and altering CDK1 expression.
Wang LL; Sun KX; Wu DD; Xiu YL; Chen X; Chen S; Zong ZH; Sang XB; Liu Y; Zhao Y
J Cell Mol Med; 2017 Nov; 21(11):3055-3065. PubMed ID: 28598010
[TBL] [Abstract] [Full Text] [Related]
3. MicroRNA-490-3P targets CDK1 and inhibits ovarian epithelial carcinoma tumorigenesis and progression.
Chen S; Chen X; Xiu YL; Sun KX; Zhao Y
Cancer Lett; 2015 Jun; 362(1):122-30. PubMed ID: 25819031
[TBL] [Abstract] [Full Text] [Related]